Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer
Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer have?
Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer has 118 citations in the OpenAlex counts ScholarIQ stores.
When was Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer published?
Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer has 2012 year in the ScholarIQ index.
What is the open-access status of Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer?
Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer has hybrid oa status in the ScholarIQ index.
What is the DOI of Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer?
The DOI for Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer is on the source record.
What is the PMID of Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer?
The PMID for Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer is on the source record.
What is the OpenAlex record for Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer?
The OpenAlex for Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer is on the source record.